Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Controlled Release

• Publication date

  2017-09-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2017.07.009PMID 28694032PMCID PMC5824426
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma‐Tailored Gene Panel

  2017cited by this paper
• PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

  2016cited by this paper
• Enhancing Intracranial Delivery of Clinically Relevant Non-viral Gene Vectors.

  2016cited by this paper
• Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain.

  2016cited by this paper
• Highly branched poly(β-amino ester)s for skin gene therapy.

  2016cited by this paper
• Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy

  2015cited by this paper
• Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo

  2015cited by this paper
• Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.

  2015cited by this paper
• Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis

  2015cited by this paper
• Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.

  2015cited by this paper
• Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.

  2015cited by this paper
• Glioblastoma: Defining Tumor Niches.

  2015cited by this paper
• Particle tracking in drug and gene delivery research: State-of-the-art applications and methods.

  2015cited by this paper
• Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain

  2015cited by this paper
• MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.

  2015cited by this paper
• Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.

  2014cited by this paper
• Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain

  2014cited by this paper
• Retro-inverso CendR peptide-mediated polyethyleneimine for intracranial glioblastoma-targeting gene therapy.

  2014cited by this paper
• Polymers for nucleic acid transfer-an overview.

  2014cited by this paper
• Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration

  2014cited by this paper
• Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo

  2014cited by this paper
• DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancer.

  2014cited by this paper
• Glioblastoma and other malignant gliomas: a clinical review.

  2013cited by this paper
• Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors (RRV) in a rodent brain tumor model

  2013cited by this paper
• Novel polyethylenimine-derived nanoparticles for in vivo gene delivery

  2013cited by this paper
• Development of poly(β-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA.

  2013cited by this paper
• Multifunctional receptor-targeted nanocomplexes for the delivery of therapeutic nucleic acids to the brain.

  2013cited by this paper
• Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model

  2013cited by this paper
• Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer.

  2013cited by this paper
• Lipid peptide nanocomplexes for gene delivery and magnetic resonance imaging in the brain

  2012cited by this paper
• The art of gene therapy for glioma: a review of the challenging road to the bedside

  2012cited by this paper
• Interstitial guidance of cancer invasion

  2012cited by this paper
• Viral Vectors for Gene Transfer

  2012cited by this paper
• A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue

  2012cited by this paper
• Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

  2011cited by this paper
• A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.

  2011cited by this paper
• Gene therapy for high-grade glioma.

  2010cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats.

  2010cited by this paper
• Combination of Intracranial Temozolomide With Intracranial Carmustine Improves Survival When Compared With Either Treatment Alone in a Rodent Glioma Model

  2010cited by this paper
• Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer

  2009cited by this paper
• Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas

  2009cited by this paper
• Designer Therapies for Glioblastoma Multiforme

  2008cited by this paper
• Searching for a cure: Gene therapy for glioblastoma

  2008cited by this paper
• Rapid Optimization of Gene Delivery by Parallel End-modification of Poly(β-amino ester)s.

  2007cited by this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007cited by this paper
• Gene Delivery Properties of End-Modified Poly(β-amino ester)s

  2007cited by this paper
• Gene delivery properties of end-modified poly(beta-amino ester)s.

  2007cited by this paper
• Rapid optimization of gene delivery by parallel end-modification of poly(beta-amino ester)s.

  2007cited by this paper
• Plasmid Engineering for Controlled and Sustained Gene Expression for Nonviral Gene Therapy

  2006cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating.

  2005cited by this paper
• Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters).

  2005cited by this paper
• Beta-amino ester polymers facilitate in vivo DNA transfection and adjuvant plasmid DNA immunization.

  2005cited by this paper
• Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters).

  2005cited by this paper
• Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis-Platinum and Irradiated with Monochromatic Synchrotron X-Rays

  2004cited by this paper
• EB1 is essential during Drosophila development and plays a crucial role in the integrity of chordotonal mechanosensory organs.

  2004cited by this paper
• AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study.

  2004cited by this paper
• Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution

  2004cited by this paper
• PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles.

  2004cited by this paper
• Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.

  2003cited by this paper
• Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery.

  2003cited by this paper
• Cost of migration: invasion of malignant gliomas and implications for treatment.

  2003cited by this paper
• Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses

  2003cited by this paper
• Synthesis of poly (β-amino ester)s optimized for highly effective gene delivery

  2003cited by this paper
• Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir.

  2003cited by this paper
• Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

  2003cited by this paper
• Strain-based Genetic Differences Regulate the Efficiency of Systemic Gene Delivery as Well as Expression*

  2002cited by this paper
• Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

  2001cited by this paper
• Anticancer drug resistance in primary human brain tumors.

  2001cited by this paper
• Principles of Medical Statistics

  2001cited by this paper
• DNA/polyethylenimine transfection particles: Influence of ligands, polymer size, and PEGylation on internalization and gene expression

  2001cited by this paper
• O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.

  2000cited by this paper
• The p16/Cdkn2a/Ink4a Gene Is Frequently Deleted in Nitrosourea-Induced Rat Glial Tumors

  1999cited by this paper
• A Phase 1-2 Clinical Trial of Gene Therapy for Recurrent Glioblastoma Multiforme by Tumor Transduction with the Herpes Simplex Thymidine Kinase Gene Followed by Ganciclovir

  1999cited by this paper
• A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase "Suicide" Gene Therapy for Recurrent Glioblastoma

  1998cited by this paper
• A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

  1998cited by this paper
• Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors

  1997cited by this paper
• Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.

  1996cited by this paper
• Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells.

  1996cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

  1995cited by this paper
• Convection-enhanced delivery of macromolecules in the brain.

  1994cited by this paper
• Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.

  1993cited by this paper
• Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.

  1991cited by this paper
• Suppression of human colorectal carcinoma cell growth by wild-type p53.

  1990cited by this paper

• A combination of systemic mannitol and mannitol modified polyester nanoparticles for caveolae-mediated gene delivery to the brain

  2025cites this paper
• Convection-enhanced delivery for brain malignancies: Technical parameters, formulation strategies and clinical perspectives.

  2025cites this paper
• Polymeric nanoparticle-mediated GBA1 gene therapy is neuroprotective in a preclinical model of Parkinson’s disease

  2025cites this paper
• Biomedical functions and applications of nanomaterials in tumor diagnosis and treatment: perspectives from ophthalmic oncology

  2025cites this paper
• Unleashing Translational Opportunities of Loco-Regional Drug Delivery to Treat Malignancy

  2025cites this paper
• Advances in locally administered nucleic acid therapeutics

  2025cites this paper
• Enhancing brain tumor classification through deep learning-based analysis of genetic data

  2025cites this paper
• A journey through the history of PEGylated drug delivery nanocarriers

  2024cites this paper
• Brain Nucleic Acid Delivery and Genome Editing via Focused Ultrasound-Mediated Blood-Brain Barrier Opening and Long-Circulating Nanoparticles.

  2024cites this paper
• Next-generation DNA-enhanced electrochemical energy storage: Recent advances and perspectives

  2024cites this paper
• A Compact Review on State-of-the-Art Brain Tumor Classification Models

  2024cites this paper
• Sugar alcohol-modified polyester nanoparticles for gene delivery via selective caveolae-mediated endocytosis.

  2024cites this paper
• Delivery of nucleic acids using nanomaterials

  2023cites this paper
• Development of microRNA-based therapeutics for central nervous system diseases.

  2023cites this paper
• Bioreducible Gene Delivery Platform that Promotes Intracellular Payload Release and Widespread Brain Dispersion.

  2023cites this paper
• Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials

  2023cites this paper
• A Highly Translatable Dual-arm Local Delivery Strategy To Achieve Widespread Therapeutic Coverage in Healthy and Tumor-bearing Brain Tissues.

  2023cites this paper
• Advances in the Development of Biodegradable Polymeric Materials for Biomedical Applications

  2022cites this paper
• Formulation and Evaluation of Polymer‐Based Nanoparticles for Intravitreal Gene‐Delivery Applications

  2022cites this paper
• Mannosylated Polycations Target CD206+ Antigen-Presenting Cells and Mediate T-Cell-Specific Activation in Cancer Vaccination

  2022cites this paper
• Current Landscape and Emerging Opportunities of Gene Therapy with Non-Viral Episomal Vectors.

  2022cites this paper
• Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

  2022cites this paper
• Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches

  2022influential citation
• Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy

  2022cites this paper
• Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy

  2022cites this paper
• Overcoming barriers in non-viral gene delivery for neurological applications.

  2022cites this paper
• A Multi-Objective Randomly Updated Beetle Swarm and Multi-Verse Optimization for Brain Tumor Segmentation and Classification

  2021cites this paper
• Amplify antimicrobial photo dynamic therapy efficacy with poly-beta-amino esters (PBAEs)

  2021cites this paper
• Engineering nanoparticles to overcome the mucus barrier for drug delivery: Design, evaluation and state-of-the-art

  2021cites this paper
• Poly (β amino esters) Copolymers: Novel Potential Vectors for Delivery of Genes and Related Therapeutics.

  2021cites this paper
• Strategies to Enhance the Distribution of Therapeutic Nanoparticles in the Brain by Convection Enhanced Delivery

  2020cites this paper
• Green nanomedicine: the path to the next generation of nanomaterials for diagnosing brain tumors and therapeutics?

  2020cites this paper
• Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury.

  2020cites this paper
• Poly(ethylene glycol)-Poly(beta-amino ester)-Based Nanoparticles for Suicide Gene Therapy Enhance Brain Penetration and Extend Survival in a Preclinical Human Glioblastoma Orthotopic Xenograft Model.

  2020cites this paper
• Brain tumor segmentation and classification via adaptive CLFAHE with hybrid classification

  2020cites this paper
• Non-adhesive and highly stable biodegradable nanoparticles that provide widespread and safe transgene expression in orthotopic brain tumors

  2020cites this paper
• Recent advances on anti-tumor agents-loaded polymeric and lipid based nano-carriers for the treatment of brain cancer.

  2020cites this paper
• Evaluation of Biodistribution, Toxicology, and Toxicologic Pathology of Nanomaterials Used to Deliver Nucleic Acids

  2019cites this paper
• Biodegradable Nanoparticles for Drug Delivery and Targeting

  2019cites this paper
• Recent Advances in the Use of Focused Ultrasound for Magnetic Resonance Image-Guided Therapeutic Nanoparticle Delivery to the Central Nervous System

  2019cites this paper
• Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

  2019cites this paper
• Disease-directed engineering for physiology-driven treatment interventions in neurological disorders

  2019cites this paper
• Focused Ultrasound Preconditioning for Augmented Nanoparticle Penetration and Efficacy in the Central Nervous System.

  2019cites this paper
• Biodegradable Polymers for Gene Delivery

  2019cites this paper
• Poly(β-amino ester)-based gene delivery systems: From discovery to therapeutic applications.

  2019cites this paper
• Widespread gene transfer to malignant gliomas with In vitro-to-In vivo correlation.

  2019cites this paper
• Biodegradable Gene Carriers Containing Rigid Aromatic Linkage with Enhanced DNA Binding and Cell Uptake

  2018cites this paper
• Rapid formulation of redox-responsive oligo-β-aminoester polyplexes with siRNA via jet printing.

  2018cites this paper
• Hypoxia-tropic Protein Nanocages for Modulation of Tumor- and Chemotherapy-Associated Hypoxia.

  2018cites this paper
• Poly(β‐Amino Esters): Synthesis, Formulations, and Their Biomedical Applications

  2018cites this paper
• Aurora kinase B siRNA-loaded lactoferrin nanoparticles potentiate the efficacy of temozolomide in treating glioblastoma.

  2018cites this paper
• Conjugates toward medicines

  2017cites this paper
• Strategies to enhance the distribution of nanotherapeutics in the brain

  2017cites this paper